JEFFERSON, N.C., Aug. 3 /CNW/ -- Next Safety, Inc. will begin to sample
its proprietary pulmonary device that has proven to have higher efficacy than
cigarettes and unlike tobacco products does not contain carcinogens. Tobacco
is the second leading cause of death globally; 600 million persons smoking
today will die prematurely from their habit.
(Photo: http://www.newscom.com/cgi-bin/prnh/20070629/CLF019 )
The company will begin sampling devices to select reporters in Boston on
Tuesday, August 14th and Wednesday, August 15th; in Washington D.C. on
Thursday, August 16th and Friday August 17th; and in New York on Monday,
August 20th. In addition, the company will hold a moderated discussion at the
Mandarin Oriental in New York on Tuesday, August 21st. Attendees will include:
leading pulmonologists and oncologists, reporters and public officials, as
well as smokers and non-smokers.
Next Safety moved into a new 32,000 square feet facility on July 27th.
During the next eighteen months Next Safety expects to occupy 850,000 square
feet of additional office/manufacturing space and hire approximately 3,600
For further information:
For further information: Christy Cheek of Next Safety Inc.,
firstname.lastname@example.org, +1-336-246-7700 ext. 230, 1-888-336-PURE Web